Glycosaminoglycan analogs as a novel anti-inflammatory strategy
about
Reducing the inflammatory responses of biomaterials by surface modification with glycosaminoglycan multilayers.Chemokine cooperativity is caused by competitive glycosaminoglycan binding.The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pHSynthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology.Heparin and related drugs: beyond anticoagulant activity.Blood vessels pattern heparan sulfate gradients between their apical and basolateral aspects.Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.Chemokines and GlycosaminoglycansMechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.Transendothelial migration of effector T cells across inflamed endothelial barriers does not require heparan sulfate proteoglycans.The bittersweet taste of tubulo-interstitial glycans.Protective role of heparin in the injury of the liver and kidney on the experimental model of ischemia/reperfusion.Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System.What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention?RANTES/CCL5 Induces Collagen Degradation by Activating MMP-1 and MMP-13 Expression in Human Rheumatoid Arthritis Synovial Fibroblasts.Heparin Mimetics: Their Therapeutic Potential.Serum Syndecan-4 as a Possible Biomarker in Patients With Acute Pneumonia.
P2860
Q30316046-DD39FCD8-65F2-4666-80F4-F2410F24D4C3Q34344569-1CBD107C-593B-45C7-A464-4457A3F65C37Q35860612-612901E6-1A61-4E08-BF19-D857196AC84BQ36169514-837060C2-6A02-4929-B186-6DBF1D9CC81AQ37105310-782DC754-6DC8-4318-AC70-EEE46C89FFF4Q37505173-FBE5561B-3B91-4D6C-85AE-737A4232F7B5Q38116039-69E7EBA9-830A-4424-9FCE-9A7B69C67C9CQ38527812-C1A39504-847A-4827-AF44-3CA831CA5147Q38658691-A913D32D-7DF7-4C48-9918-54649B921CE6Q39036330-63262F79-7FBD-49C1-A4D8-DF144B565FB2Q39240506-7EAAED8C-FC55-4A92-AD84-DC6C683EA070Q41891089-63064291-E474-4132-9FA0-3ACE6E6B3E4AQ42366882-27D4647A-FE20-4C58-B728-2C84FB474B93Q42777722-4A142490-39E0-4E0B-A57A-EFAD207D6A6DQ47140595-5872F747-6F0D-43C3-9283-9AF45917A772Q47159791-C8E7DFB6-95F4-41D8-BD95-5ADE1CF2F5DCQ52949851-A4822D56-948D-4EB6-BC8C-4E01D7F383C3
P2860
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
@ast
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
@en
type
label
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
@ast
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
@en
prefLabel
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
@ast
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
@en
P2093
P2860
P356
P1476
Glycosaminoglycan analogs as a novel anti-inflammatory strategy
@en
P2093
Adriano Soares
Alexander Scheer
Amanda E I Proudfoot
Daniela Sachs
Delphine Valognes
India C Severin
Jeffrey Shaw
Jennifer Hantson
Matthias K Schwarz
Mauro Teixeira
P2860
P356
10.3389/FIMMU.2012.00293
P577
2012-10-16T00:00:00Z